Strong Orders, Weak Ramp—Capacity Execution Risk

TARIL's earnings print arrived with two faces. The order book (+26% YoY to ₹6,630 Cr) and Q1 inflow (₹2,114 Cr, anchored by a ₹1,000+ Crore PGCIL mega-order) told one story: robust demand and pricing power. But the revenue print (₹572.3 Cr, +8.1% YoY) and profitability (PAT ₹64.3 Cr, -4.7% YoY) told another. The gap between order visibility and execution is the quarter, and management's explanation—temporary Changodar capacity constraints—doesn't reconcile with Moraiya's persistent underutilization (57% in Q1, expected to stay 60–65% through FY27). When pressed why a plant with a ₹6,630 Crore order book runs at half of competitor capacity, the CFO said: 'no major reason.' That deflection cost the stock 11.93% by day 3.

In Q4 FY26, management guided for 35–40% revenue growth in FY27, targeting ₹3,250 Crore. That was revised down to 25% growth (₹3,125 Cr implied) on this call. Q1 already shows the trajectory is adrift: at 8.1% YoY growth, the quarter would need to accelerate dramatically to hit the reset target. Management attributed the shortfall to Changodar plant expansion (27% utilization in Q1, ramp expected to 60–65% by year-end). Fair. But Moraiya, the larger and fully operational plant, is also at only 57% utilization. Management has a history of delays at Changodar (monsoon, labor, engineering mods), and the 'revised execution schedule' is now the third timeline shift. More troubling: the company has already downgraded guidance once; if Q2 revenue remains in the 8–12% YoY range, a second cut to 15–20% growth is probable, straining the ₹8,000 Crore FY29 target.

TARIL's PAT declined 4.7% YoY despite revenue growing 8.1%—a red flag for margin compression. Q1 consolidated EBITDA was ₹110 Cr (19.2% margin), but the subsidiary cushions the transformer business. Standalone transformer EBITDA was ₹87 Cr (15.6%)—below the 16% FY27 guidance. Management claims pricing discipline via price variation clauses, but the PnL contradicts this. PAT margin of 8.9% in Q1 is below the 9–10% FY27 guidance. The stated remedy: backward integration (CTC Q2, Pressboard Q3, Bushing Q4, Fabrication Q1 FY28) will unlock 200–300 basis points of margin uplift from FY28 onwards. None of that accretion is visible in Q1, and it's contingent on facility ramps that haven't yet happened. Worse, depreciation will offset some benefit in FY28, delaying the full 200–300 bps until FY29. Working capital is stretched to 170 days (inventory 85 days, receivables 130 days) due to deliberate raw material hoarding through December 2026 for geopolitical protection. This inflates short-term financing costs.

Three substantive shifts from prior guidance:

Management frames these downgrades as 'being realistic' rather than a miss, but the pattern is clear: expectations have reset downward twice, execution lags guidance, and the turnaround levers (backward integration, capacity ramp) are yet to fire.

The market rejected the print decisively. On day 1 after the announcement, the stock fell 5.16% from the pre-result close of ₹333.55. By day 3, the decline had widened to 11.93%, landing the stock at ₹295.7. This is not a snap-back sell-off—it's a repricing downward. The stock now trades 41% below its all-time high (₹501.25), well below its 20-day (₹332.57), 50-day (₹323.85), and 200-day (₹316.78) moving averages. RSI of 28.5 signals oversold conditions, but the market's message is unambiguous: the execution risk is real, and Q1 did not dispel it. FII ownership has declined from 11.33% (Q4 FY25) to 8.33% (Q4 FY26)—a 300 basis point trimming by foreign investors. Domestic institutional ownership has also waned (4.19% DII in Q3 FY26 → 1.77% in Q4 FY26). Even local money doubts the near-term story.